cholecystectomy final

Upload: jeg-b-israel-jr

Post on 04-Jun-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 Cholecystectomy Final

    1/19

    CHAPTER I INTRODUCTION

    Cholecystitis is an inflammation of the gallbladder wall and nearby abdominal lining. Cholecystitis is

    usually caused by a gallstone in the cystic duct, the duct that connects the gallbladder to the hepatic

    duct. The presence of gallstones in the gallbladder is called cholelithiasis. Cholelithiasis is the pathologic

    state of stones or calculi within the gallbladder lumen. A common digestive disorder worldwide, the

    annual overall cost of cholelithiasis is approximately $5 billion in the United States, where 75-80% of

    gallstones are of the cholesterol type, and approximately 10-25% of gallstones are bilirubinate of either

    black or brown pigment. In Asia, pigmented stones predominate, although recent studies have shown an

    increase in cholesterol stones in the Far East .Gallstones are crystalline structures formed by concretion

    (hardening) or accretion(adherence of particles, accumulation) of normal or abnormal bile constituents

    .According to various theories, there are four possible explanations for stone formation. First, bile may

    undergo a change in composition. Second, gallbladder stasis may lead to bile stasis. Third, infection may

    predispose a person to stone formation. Fourth, genetics and demography can affect stone formation.

    Risk factors associated with development of gallstones include heredity, Obesity, rapid weight loss,

    through diet or surgery, age over 60, Native American or Mexican American racial makeup, female

    gender-gallbladder disease is more common in women than in men. Women with high estrogen levels,

    as a result of pregnancy, hormone replacement therapy, or the use of birth control pills, are at

    particularly high risk for gallstone formation, Diet-Very low calorie diets, prolonged fasting, and low-

    fiber /high-cholesterol/high-starch diets all may contribute to gallstone formation. Sometimes, persons

    with gallbladder disease have few or no symptoms. Others, however, will eventually develop one or

    more of the following symptoms; (1) Frequent bouts of indigestion, especially after eating fatty or

    greasy foods, or certain vegetables such as cabbage, radishes, or pickles, (2) Nausea and bloating (3)

    Attacks of sharp pains in the upper right part of the abdomen. This pain occurs when a gallstone causesa blockage that prevents the gallbladder from emptying (usually by obstructing the cystic duct). (4)

    Jaundice (yellowing of the skin) may occur if a gallstone becomes stuck in the common bile duct, which

    leads into the intestine blocking the flow of bile from both the gallbladder and the liver. This is a serious

    complication and usually requires immediate treatment. The only treatment that cures gallbladder

    disease is surgical removal of the gallbladder, called cholecystectomy. Generally, when stones are

    present and causing symptoms, or when the gallbladder is infected and inflamed, removal of the organ

    is usually necessary. When the gallbladder is removed, the surgeon may examine the bileducts,

    sometimes with X rays, and remove any stones that may be lodged there. The ducts are not removed so

    that the liver can continue to secrete bile into the intestine. Most patients experience no further

    symptoms after cholecystectomy. However, mild residual symptoms can occur, which can usually becontrolled with a special diet and medication.

  • 8/13/2019 Cholecystectomy Final

    2/19

    CHAPTER II ASSESSMENT

    A. Nursing Health History

    Personal Data

    Name: Mrs. Dina Natuto

    Age: 70 years old

    Gender: Female

    Status: Married

    Address: Pob. San Manuel, Tarlac

    Date of Birth: Nov. 23, 1943

    Place of Birth: Nueve Ecija

    Religion: Roman Catholic

    Date of Admission: Nov. 30, 2013

    Time of Admission: 3:10pm

    Chief Compliants: chills and abdominal plain

    Final diagnosis: Hydrops of gallbladder secondary to cholecystolithiasis multiple

    Opreation: E RUQ exploration,adhesiolysis, cholecystectomy with IOC( Intra-operative Cholangiogram), Common Bile Duct - exploration, T- tube

    choledochostomy.

    Past Medical History

    Present Medical History

    3 days prior to admission (+) fever on and off. 1 day prior to admission (+) abdominal pain at the hypogastric area to epigastric area associated

    with chills.

    Family Health History

  • 8/13/2019 Cholecystectomy Final

    3/19

    B. Physical Assessments

    Physical Assessment done by the attending physician reveals that patient is;

    Febrile pale anicteric sclera pinkish palpebral conjunctiva symmetrical chest expression fair pulse (-) cyanosis (+) NABS non tender abdomen

    Vital Signs upon admission (Nov. 30, 2013)

    o BP- 130/80 mmHgo RR-20 cpmo PR-89 bpmo Temp-38 C

    Physical Assessment done by the student reveals that patient is;

    Febrile Warm to touch pale and weak looking (+) dry lips (+) dry skin decreased skin turgor

    Vital Signs taken and recorded as of (Nov. 30, 2013) are as follows;

    o BP- 130/80 mmHgo RR-20 cpmo PR-89 bpmo Temp-38 C

    C. Laboratory Exams

    1. Complete Blood Count (CBC)

    This is to determine blood components and the response to inflammatory process and streptococcal

    infection.

  • 8/13/2019 Cholecystectomy Final

    4/19

    Date Ordered: Nov. 30, 201

    Date Result In: Nov. 30, 2013

    Results:

    WBC - 14.5 g/l

    RBC - 3.73 g/l

    Lymphocytes - 0.15 g/l

    Monocytes - 0.08 g/l

    Granulocytes - 0.77 g/l

    Hemoglobin126 g/l

    Hematocrit - 0.34 g/l

    Platelet count357 g/l

    Repeat CBC

    Date Ordered: Dec. 1, 2013

    Date Result In: Dec. 1, 2013

    Results:

    WBC - 18 g/l

    RBC - 3.71 g/l

    Lymphocytes - 0.04 g/l

    Monocytes - 0.06 g/l

    Granulocytes - 0.90 g/l

    Hemoglobin106 g/l

    Hematocrit - 0.29 g/l

    Conclusion: WBC is slightly elevated based on the normal value of 5.0-10 g/l which confirms the

    presence of infection.

  • 8/13/2019 Cholecystectomy Final

    5/19

    2. Serum Electrolytes

    Date Ordered: Nov.30, 2013

    Date Result in: Nov.30,2013

    Results:

    Serum Sodium - 135.7 mmol/L

    Potassium - 3.25 mmol/L

    Chloride - 98.1 mmol/L

    Repeat Serum Electrolytes

    Date Ordered: Dec.1 ,2013

    Date Result In: Dec. 1, 2013

    Results:

    Potassium - 3.24 mmol/L

    Date Ordered: Dec. 6, 2013

    Date Result in: Dec. 6, 2013

    Results:

    Serum Sodium138.1 mmol/L

    Potassium2.83 mmol/L

    Conclusion: The potassium level is below the normal value of 3.40-5.60 mmol/L. While the sodium level

    is within nomal range based on the normal value of 134.0-148.0 mmol/L.

    3. Creatinine

    This is the indicator of the renal function.

    Date Ordered: Dec. 4, 2013

  • 8/13/2019 Cholecystectomy Final

    6/19

    Result In: Dec. 4, 2013

    Results: 0.8mg/dl

    Conclusions: The result is within normal range based on the normal value of 0.5 - 1.7mg/dl.

    4. BUN

    This is an indicator of renal function and perfusion, dietary intake of CHON and the level of

    protein metabolism.

    Date Ordered: Dec. 4, 2013

    Date Result In: Dec. 4, 2013

    Results: 5.3 mg/dl

    Conclusions: The result is within normal range based on the normal value of mg/dl.

    5. Urinalysis

    Urinalysis yields a large amount of information about possible disorders of the kidney and lower

    urinary tract, and systematic disorders that alter urine composition. Urinalysis data include color,

    specific gravity, pH, and the presence of protein, RBCs, WBCs, bacteria, Leukocyte, esterase, bilirubin,

    glucose, ketones, casts and crystals.

    Date Ordered: February 10, 2006

    Date Result In: February 10, 2006

    Results: Color- yellow Specific Gravity- 0.010

    Sugar/ Albumin- negative Pus cells- 0.1 hpf

    Conclusions: The results are normal but there is a presence of pus cells in the urine which means that

    there is also the presence of infection.

  • 8/13/2019 Cholecystectomy Final

    7/19

    D. Anatomy and Physiology

    Gallbladder, muscular organ that serves as a reservoir for bile, present in most vertebrates.

    In humans, it is a pear-shaped membranous sac on the undersurface of the right lobe of the liver just

    below the lower ribs. It is generally about 7.5 cm (about 3 in)long and 2.5 cm (1 in) in diameter at its

    thickest part; it has a capacity varying from 1 to1.5 fluid ounces. The body (corpus) and neck (collum) ofthe gallbladder extend backward, upward, and to the left. The wide end (fundus) points downward and

    forward, sometimes extending slightly beyond the edge of the liver. Structurally, the gallbladder consists

    of an outer peritoneal coat (tunica serosa); a middle coat of fibrous tissue and unstriped muscle (tunica

    muscularis); and an inner mucous membrane coat (tunica mucosa).The function of the gallbladder is to

    store bile, secreted by the liver and transmitted from that organ via the cystic and hepatic ducts, until it

    is needed in the digestive process. The gallbladder, when functioning normally, empties through the

    biliary ducts into the duodenum to aid digestion by promoting peristalsis and absorption, preventing

    putrefaction, and emulsifying fat. Digestion of fat occurs mainly in the small intestine, by pancreatic

    enzymes called lipases. The purpose of bile is to; help the Lipases to Work, by emulsifying fat into

    smaller droplets to increase access for the enzymes, Enable intake of fat, including fat-soluble vitamins:

    Vitamin A, D, E, and K, rid the body of surpluses and metabolic wastes Cholesterol and Bilirubin.

  • 8/13/2019 Cholecystectomy Final

    8/19

    E. Pathophysiology

  • 8/13/2019 Cholecystectomy Final

    9/19

  • 8/13/2019 Cholecystectomy Final

    10/19

    Risk factor

    Heredity Obesity Rapid Weight Loss, through diet or surgery Age Over 60

    Bile must become supersaturated with cholesterol and calcium The solute precipitate from solution as

    solid crystals Crystals must come together and fuse to form stones Gallstones Obstruction of the cystic

    duct and common bile duct Sharp pain in the right part of abdomen Jaundice Distention of the gall

    bladder Venous and lymphatic drainage is impaired Proliferation of bacteria Localized cellular irritation

    or infiltration or both take place Areas of ischemia may occur Inflammation of gall bladder

    CHOLECYSTITIS

    CHAPTER III PLANNING

    A. List of Prioritized Nursing Diagnosis

    Pre-operative nursing diagnosis: Acute pain

    Knowledge Deficit

    Disturbed sleeping pattern

    Intra-operative nursing diagnosis Deficient Fluid Volume

    Post-operative nursing diagnosis: Risk for infection

    Ineffective Coping

    B. Nursing Care Plan

    1. Acute Pain

    Cues Nursing

    Diagnosis

    Scientific

    Explanation

    Objective Nursing

    Intervention

    Rationale Evaluation

    S- ang

    sakit ng

    tyan ko

    as

    claimed

    by thepatient.

    O-(+)

    guarding

    behavior

    , pain

    scale of

    Acute pain

    related to

    inflammati

    on and

    distortion

    of thegallbladder

    as

    evidenced

    by verbal

    reports of

    pain.

    Due to the

    presence of

    stones in

    the

    gallbladder

    it causessome

    obstruction

    in the cystic

    duct which

    in turn

    causes a

    sharp acute

    After 4

    hours of

    nursing

    intervent

    ion the

    patientwill

    report

    relieve of

    pain.

    1. Observe

    and document

    location,

    severity (0

    10scale), and

    character ofpain (e.g.,

    steady,

    intermittent,

    colicky). 2.

    Promote bed

    rest, allowing

    patient to

    - Assists in

    differentiating

    cause of pain,

    and provides

    information

    about diseaseprogression/r

    esolution,

    development

    of

    complications,

    and

    effectiveness

    Is there a change

    on the patients;

    a. Pain scale

    b. RR

    c. BP

    d. Reports ofpain.

    e. Facial

    expressions.

  • 8/13/2019 Cholecystectomy Final

    11/19

    7/10,

    difficulty

    in

    moving

    as

    manifest

    ed by

    facial

    grimaces

    -(+)

    pallor,

    V/S as

    follows:

    BP -

    130/80

    mmHg,

    PR- 89

    bpm,RR-

    20cpm,

    T- 38C

    pain on the

    right part of

    the

    abdomen.

    assume

    position of

    comfort. 3.

    Control

    environmental

    temperature.

    4. Encourage

    use of

    relaxation

    techniques,

    e.g., guided

    imagery,

    visualization,

    deep-

    breathing

    exercises.

    Provide

    diversionalactivities. 5.

    Make time to

    listen to and

    maintain

    frequent

    contact with

    patient. 6.

    Administer

    analgesics as

    indicated.

    of

    interventions.

    - Bed rest in

    low-Fowlers

    position

    reduces intra-

    abdominal

    pressure;

    however,

    patient will

    naturally

    assume least

    painful

    position.

    - Cool

    surroundings

    aid in

    minimizingdermal

    discomfort.-

    Promotes

    rest, redirects

    attention,

    may enhance

    coping.-

    Helpful in

    alleviating

    anxiety and

    refocusingattention,

    which can

    relieve pain.-

    Relief of pain

    facilitates

    cooperation

    with other

    therapeutic

    interventions.

    2. Fluid Volume Deficit

    Cues Nursing

    Diagnosis

    Scientific

    Explanation

    Objective Nursing

    Intervention

    Rationale Evaluation

    S - Deficient There is this After an 1. Provide - Information -Does the patient

  • 8/13/2019 Cholecystectomy Final

    12/19

    pwede

    bang

    maulit

    ang sakit

    ko as

    verbaliz

    ed by

    the

    patient

    O-

    Frequen

    tly

    asking

    question

    about

    his

    conditio

    n,treatme

    nt and

    diet

    -With

    worried

    gaze dry

    mouth

    knowledge

    related to

    condition,

    prognosis,

    treatment,

    self - care,

    and

    discharge

    needs

    presence of

    knowledge

    deficit due

    to some

    unfamiliar

    information

    that causes

    some

    confusion to

    the client

    that needs

    to be

    discussed.

    hour of

    nurse-

    patient

    interacti

    on the

    patient

    will

    verbalize

    understa

    nding of

    disease

    process,

    prognosi

    s, and

    potential

    complica

    tions

    explanations

    of reasons for

    test

    procedures

    and

    preparation

    needed.

    2. Review

    disease

    process/

    prognosis.

    Discuss

    hospitalization

    and

    prospective

    treatment as

    indicated.

    Encouragequestions,

    expression of

    concern.

    3. Review

    drug regimen,

    possible side

    effects

    4. Instruct

    patient to

    avoid

    food/fluidshigh in fats

    (e.g., whole

    milk, ice

    cream, butter,

    fried foods,

    nuts, gravies,

    pork), gas

    producers

    (e.g., cabbage,

    beans, onions,

    carbonated

    beverages), or

    gastric

    irritants(e.g.,

    spicy foods,

    caffeine,

    citrus).

    5. Suggest

    patient limit

    can decrease

    anxiety,

    thereby

    reducing

    sympathetic

    stimulation.

    - Provides

    knowledge

    base from

    which

    patient can

    make

    informed

    choices. - -----

    - Effective

    communicati

    on and

    support atthis time can

    diminish

    anxiety and

    promote

    healing.

    - Gallstones

    often recur,

    necessitating

    long-term

    therapy.

    - Prevents/limits

    recurrence of

    gallbladder

    attacks.

    -

    Promotes gas

    formation,

    which can

    increase

    gastric

    distension/

    discomfort.

    understands and

    could recall all the

    teachings given?

    -Is there a

    significant changes

    that occur on the

    patients

    knowledge

    regarding;

    a.disease

    condition b.diet

    c.treatment

    d.medication

    e.self-care needs

  • 8/13/2019 Cholecystectomy Final

    13/19

    gum chewing,

    sucking on

    straw/hard

    candy, or

    smoking

    C. Drug Study

    Name of Drug Route/

    Dosage

    andFrequency

    Action Indication Adverse

    Reaction

    Nursing

    Consideration

    GN:Cefuroxime

    BN: Zinacef

    750 mg IV

    Q8hrs

    ANST(-)

    -

    Anti-infectives

    -Second-

    generation

    cephalosphorin

    that inhibits cell-

    wall synthesis,

    promoting

    osmotic

    instability;

    usually

    bactericidal

    Perioperative

    prevention

    Phlebitis,

    nausea,

    anorexia,vomiti

    ng,

    maculopapular

    and

    erythematous

    rashes,

    urticarial, pain,

    induration

    1.Check the

    doctors order.

    2. Inform the

    patient about

    the adverse

    reaction.

    3. Before giving

    drug, ask

    patient if he is

    allergic to

    penicillins or

    cephalosphorin

    s.

    4. Intsruct

    patient to

    notify

    prescriber

    about rash,

    loose stools,

    diarrhea, or

    evidence of

    superinfection.5. Advise

    patient

    discomfort

    receiving drug

    IV to report

    discomfort at

    IV insertion

  • 8/13/2019 Cholecystectomy Final

    14/19

    site.

    GN: Cefoxitin

    Sodium

    BN: Mefoxitin

    1gm IV

    Q8hrs

    ANST(-)

    -

    Anti-infectives

    -Second-

    generation

    cephalosphorin

    that inhibits cell-

    wall synthesis,

    promoting

    osmotic

    instability;

    usually

    bactericidal

    Serious

    infection of the

    respiratory and

    GU tracts; skin;

    soft-tissue,

    bone, or joint

    infection;

    blood-stream

    or intra-

    abdominal

    infection

    caused by

    susceptible

    organisms(

    such as E. coli

    and other

    coliformbacteria.

    Fever, phlebitis,

    diarrhea,

    nausea,

    vomiting,

    anemia, acute

    renal failure,

    pain, induration.

    1. Before givig

    ng drug, ask

    patient if he is

    allergic to

    penicillins or

    other

    cephalosphorin

    s. 2. After

    reconstitution,

    drug may be

    stored for

    24hrs at room

    temperature or

    1 week under

    refrigeration.

    3. Intsruct

    patient tonotify

    prescriber

    about rash,

    loose stools,

    diarrhea, or

    evidence of

    superinfection.

    4. Advise

    patient

    discomfort

    receiving drugIV to report

    discomfort at

    IV insertion

    site.

    GN:

    Metronidazole

    BN: Flagyl

    500 mg IV

    Q8hrs

    ANST(-)

    - BacterialInfectio

    ns

    caused

    by

    anaerob

    ic

    microor

    ganisms.

    - Toprevent

    postope

    rative

    infectio

    n in

    Direct- acting

    trichomonocid

    e and

    amoebicide

    that works

    inside and

    outside the

    intestines. Its

    thought to

    enter the cells

    of

    microorganism

    s that contain

    nitroreductase,

    forming

    Headache,

    seizures, fever,

    constipation,

    nausea, pain,

    edema,

    peripheral

    neuropathy

    1. Monitor liver

    function test

    results

    carefully in

    elderly

    patients. 2. Use

    cautiously in

    patients who

    take

    hepatotoxic

    drug or have

    hepatic disease

    or alcoholism.

    3. Use

    cautiously in

  • 8/13/2019 Cholecystectomy Final

    15/19

    contami

    nate or

    potencia

    lly

    contami

    nate

    colorect

    al

    surgery.

    unstable

    compounds

    that bind to

    DNA and

    inhibit

    synthesis,

    causing cell

    death.

    patients with

    history of

    blood

    dyscrasia, CNS

    disorder, or

    retinal or visual

    retinal

    changes.

    4. Record

    number and

    character of

    stool when

    drug is used to

    treat

    amoebiasis.

    5. Observe

    patient for

    edema,especially if

    hes receiving

    corticosteroids;

    Flagyl IV RTU

    may cause

    sodium

    retention.

    GN: Ketorolac

    Tromethamine

    BN: Toradol

    15 mg/ml

    IV Q6hrs

    PRN

    Short-term

    management of

    moderately

    severe, acutepain for multiple

    dose

    treatment.

    May inhibit

    prostaglandin

    synthesis, to

    produce anti-inflammatory,

    analgesics, and

    antipyretic

    effects.

    Headache,

    dizziness,

    drowsiness,

    hypertension,palpitation,

    sedation, peptic

    ulceration,

    prolonged

    bleeding time

    1. Correct

    hypovolemia

    before giving.

    2. Carefullyobserve

    patients with

    coagulopathies

    and those

    taking anti-

    coagulants.

    3. Teach

    patient signs

    and symptoms

    of GI bleeding,

    including blood

    in vomit; and

    black tarry

    stool. Tell

    patient to

    notify

    prescriber

    immediately if

    any of these

  • 8/13/2019 Cholecystectomy Final

    16/19

    occurs.

    4. Serious GI

    toxicity,

    including

    peptic ulcers

    and bleeding,

    can occur in

    patient taking

    NSAIDs,

    despite lack of

    symptoms.

    CHAPTER IV - IMPLEMENTATION

    Medical/ Surgical Management

    1. Chest X-ray- this is used to rule out respiratory causes of referred pain.

    2. Intake and Output- I&O measurement provide an other means of assessing fluid balance. This data

    provide insight into the cause of imbalance such as decrease fluid intake or increase fluid loss. These

    measurement are not that accurate as body weight, however, because of relative risk of errors in

    recording.

    3. Electrocardiogram - The ECG is an essential tool in evaluating cardiac rhythm. Electrocardiography

    detects and amplifies the very small electrical potential changes between different points on the surface

    of the body as a myocardial cell depolarize and repolarize, causing the heart to contract.

    4. O2 Inhalation - Oxygen therapies are used to provide more oxygen to the body into order to promote

    healing and health.

    5. Intravenous Rehydration - when the fluid loss is severe or life - threatening, intravenous (IV) fluids are

    used for replacement.

    6. Ultrasound (Also called sonography.) - a diagnostic imaging technique which uses high-frequency

    sound waves to create an image of the internal organs. Ultrasounds are used to view internal organs of

    the abdomen such as the liver spleen, and kidneys and to assess blood flow through various vessels.

    7. Hepatobiliary scintigraphy - an imaging technique of the liver, bile ducts, gallbladder, and upper part

    of the small intestine.

    8. Cholangiography - x-ray examination of the bile ducts using an intravenous (IV) dye (contrast).

  • 8/13/2019 Cholecystectomy Final

    17/19

    9. Percutaneous transhepatic cholangiography (PTC) - a needle is introduced through the skin and into

    the liver where the dye (contrast) is deposited and the bile duct structures can be viewed by x-ray. 10.

    10. Endoscopic retrograde cholangiopancreatography (ERCP) - a procedure that allows the physician to

    diagnose and treat problems in the liver, gallbladder, bile ducts, and pancreas. The procedure combines

    x-ray and the use of an endoscope. A long flexible, lighted tube. The scope is guided through the

    patient's mouth and throat, then through the esophagus, stomach, and duodenum. The physician can

    examine the inside of these organs and detect any abnormalities. A tube is then passed through the

    scope, and a dye is injected which will allow the internal organs to appear on an x-ray.

    11. Computed tomography scan (CT or CAT scan) - a diagnostic imaging procedure using a combination

    of x-rays and computer technology to produce cross-sectional images (often called slices), both

    horizontally and vertically, of the body. A CT scan shows detailed images of any part of the body,

    including the bones, muscles, fat, and organs. CT scans are more detailed than general x-rays.

    12. Cholecystectomy- removal of the gallbladder. This procedure may be performed to treat chronic or

    acute cholecystitis, with or without cholelithiasis, to remove a malignancy or to remove polyps.

    13. Cholecystotomy - the establishment of an opening into the gallbladder to allow drainage of the

    organ and removal of stones. A tube is then placed in the gallbladder to established external drainage.

    This is performed when the patient cannot tolerate cholecystectomy.

    14. Choledochoscopy- the insertion of a choledoscope into the common bileduct in order to directly

    visualize stones and facilitate their extraction.

    CHAPTER V DISCHARGED PLANNING

    Instructed the patient and S.O to continue medication at home as ordered.1) Tergecef ( Cefixime ) 400mg/ cap, 1 capsule once a day for 7 days. (8am)2) Ciprofloxacin ( Ciprobay ) 1 gm/tab, 1 tablet once a day for 7 days. (8am)3) Omeprazole 400mg/cap, 1 capsule twice a day (7am-7pm)4) Vestar MR 35mg/tab, 1 tablet twice a day (8am-8pm)5) Clopidogrel 75mg/tab, 1 tablet once a day (8am)6) Erdostiene 300mg/tab, 1 tablet three times a day (8am-1pm-7pm)7) Levociterizine/Montelukast 10/5, 1 tablet daily at bedtime. (9pm)8) Kalium Durule tab, 1 tablet three times a day for 6 doses. (8am-1pm-7pm)9) Celecoxib 200mg/cap, 1 capsule twice a day. (8am-8pm)

    Instructed patient to do deep breathing exercise, coughing technique while puttingpressure/splinting at the operative site, and walking as tolerated.

    Emphasized the importance of completing the drug regimen, especially the antibiotics.

  • 8/13/2019 Cholecystectomy Final

    18/19

    Encouraged patient to increase oral fluid intake. Advised patient to eat nutritious foods rich inVit.C. Advised patient avoid eating salty and fatty foods.

    Advised to return for the follow-up check-up on Monday, Dec.16,2013.

    VI Conclusion

    Cholecystitis is the inflammation of the gall bladder which is usually accompanied by gallstones

    or cholelithiasis these gallstones may block the way of toxic substances that really needs to go out, but

    due to this blockage this toxic substances are not then being expelled and are just being stored in the

    bladder for a period of time. This then causes inflammation of the gallbladder. The treatment usually

    done is the cholecystectomy. In order to lower the risk of having this kind of condition each and every

    one of us must be conscious in our diet. We should try to avoid foods which are rich in salt and fats,

    especially those foods which contains many seasonings. Though there is a saying that

    Mas masarap pag bawal

    which always pertains to the food were eating we should still be conscious on our health especially if we

    want to live longer and also to avoid those life-threatening diseases which not only shorten our life but

    causes us some financial problem. Remember also the saying

    Mahal ang magkasakit. Just like on what our patient had experience she still has to collect money for

    the operation she had underwent causing them to have debt with different persons. Let us not enjoy

    ourselves with the delicious food were eating that is rich in salts and fats but we should enjoy living

    because we have a healthy condition.

  • 8/13/2019 Cholecystectomy Final

    19/19

    VII - BIBLIOGRAPHY

    Books

    Joyce M. Black,PhD, RN, CPSN, CWCN & Jane Hokanson Hawks, DNSc, RN, BC,Medical- Surgical Nursing

    7thedition, pg.1302-1314.

    Nursing 2004 Drug Handbook, 24thEdition

    Doenges, Moorhouse, & Murr, Nurses pocket guide 9thedition.

    Online Resources

    www.facs.orghttp://tjsamson.client.web-health.com/web-

    health/topics/GeneralHealth/generalhealthsub/generalhealth/liver&gallbladder/what_gall

    bladder.htmlhttp://www.emedicine.com/emerg/topic97.htmhttp://www.emedicine.com/radio/topic163.htmhttp://www.healthsystem.virginia.edu/uvahealth/adult_liver/chole.cfmhttp://www.emedicine.co

    m/EMERG/topic98.htmMicrosoft Encarta 2004 Nursing Care Plan Content CD-ROM